0.00CHF
300.00 KCHF
486.60 MCHF
24.19 M
About MEDMIX N
Sector
Industry
CEO
Girts Cimermans
Website
Headquarters
Zug
Employees (FY)
2.66 K
ISIN
CH1129677105
FIGI
BBG012NVMDS7
medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. It operates under the Healthcare, and Consumer and Industrial segments. The Healthcare segment focuses on development, production, and marketing dispensers, cartridges, syringes, needles, mixers, and tips for dental applications; syringes, pen injectors, and auto injectors for subcutaneous delivery of biomaterials; and delivery devices for bone repair and tissue treatment. The Consumer and Industrial segment includes dispensers, cartridges, and mixers for two-component adhesives; and sealants for use in the construction, transportation, electronics, infrastructure, general industrial sectors, and DIY market. The company was founded on September 20, 2021 and is headquartered in Zug, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MEDX is 15.06 CHF — it has increased by 0.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange MEDMIX N stocks are traded under the ticker MEDX.
MEDMIX N is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDX stock is 2.57% volatile and has beta coefficient of 0.06. Check out the list of the most volatile stocks — is MEDMIX N there?
One year price forecast for MEDMIX N has a max estimate of 30.00 CHF and a min estimate of 20.00 CHF.
MEDX earnings for the last quarter are 0.18 CHF per share, whereas the estimation was 0.51 CHF resulting in a −64.71% surprise. The estimated earnings for the next quarter are 0.49 CHF per share. See more details about MEDMIX N earnings.
MEDMIX N revenue for the last quarter amounts to 248.10 M CHF despite the estimated figure of 248.80 M CHF. In the next quarter revenue is expected to reach 232.70 M CHF.
Yes, you can track MEDMIX N financials in yearly and quarterly reports right on TradingView.
MEDX stock has fallen by 3.59% compared to the previous week, the month change is a 3.46% fall, over the last year MEDMIX N has showed a 29.79% decrease.
MEDX net income for the last quarter is −7.00 M CHF, while the quarter before that showed 7.30 M CHF of net income which accounts for −195.89% change. Track more MEDMIX N financial stats to get the full picture.
Today MEDMIX N has the market capitalization of 610.10 M, it has increased by 2.15% over the last week.
Yes, MEDX dividends are paid annually. The last dividend per share was 0.50 CHF. As of today, Dividend Yield (TTM)% is 3.34%. Tracking MEDMIX N dividends might help you take more informed decisions.
MEDMIX N dividend yield was 2.63% in 2023, and payout ratio reached 6.85 K%. The year before the numbers were 2.84% and 176.55% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MEDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDMIX N stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 2.66 K employees. See our rating of the largest employees — is MEDMIX N on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDMIX N technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDMIX N stock shows the sell signal. See more of MEDMIX N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDMIX N future price: according to them, MEDX price has a max estimate of 30.00 CHF and a min estimate of 20.00 CHF. Read a more detailed MEDMIX N forecast: see what analysts think of MEDMIX N and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDMIX N EBITDA is 71.40 M CHF, and current EBITDA margin is 14.06%. See more stats in MEDMIX N financial statements.